LAG‐3 blockade with Relatlimab (BMS‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia

dc.contributor.author	Sordo Bahamonde, Christian
dc.contributor.author	Lorenzo Herrero, Seila
dc.contributor.author	González Rodríguez, Ana Pilar
dc.contributor.author	Ramírez Payer, Ángel
dc.contributor.author	González García, Esther
dc.contributor.author	López Soto, Alejandro
dc.contributor.author	González Rodríguez, Segundo
dc.date.accessioned	2021-11-09T07:34:27Z
dc.date.available	2021-11-09T07:34:27Z
dc.date.issued	2021
dc.identifier.citation	Cancers, 13(9) (2021); doi:10.3390/cancers13092112
dc.identifier.issn	2072-6694
dc.identifier.uri	http://hdl.handle.net/10651/61055
dc.description.sponsorship	This study was supported by the Spanish grant of Instituto de Salud Carlos III (PI19/01353) and FEDER European Union. CSB holds a Severo Ochoa Grant (BP19-066).
dc.language.iso	eng
dc.relation.ispartof	Cancers
dc.rights	© 2021 Los autores
dc.rights	CC Reconocimiento 4.0 Internacional
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scopus
dc.source.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104662442&doi=10.3390%2fcancers13092112&partnerID=40&md5=8d0bbf87781f96321398b37634d33add
dc.title	LAG‐3 blockade with Relatlimab (BMS‐986016) restores anti‐leukemic responses in chronic lymphocytic leukemia
dc.type	journal article
dc.identifier.doi	10.3390/cancers13092112
dc.relation.projectID	ISCIII/PI19/01353
dc.relation.projectID	Severo Ochoa/BP19-066
dc.relation.publisherversion	http://dx.doi.org/10.3390/cancers13092112
dc.rights.accessRights	open access
dc.type.hasVersion	VoR

Artículos [34664]
Investigaciones y Documentos OpenAIRE [7569]
Publicaciones resultado de proyectos financiados con fondos públicos
Medicina [893]

Este ítem está sujeto a una licencia Creative Commons